Oramed Pharmaceuticals
ORMP
#8860
Rank
A$0.13 B
Marketcap
$3.38
Share price
-1.35%
Change (1 day)
7.38%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): A$37.31 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of A$10.94 Million, an increase over its 2022 earnings that were of -A$56.28 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$37.31 M240.89%
2023 A$10.94 M-119.45%
2022 -A$56.28 Million39.17%
2021 -A$40.44 Million73.93%
2020 -A$23.25 Million18.53%
2019 -A$19.62 Million-16.62%
2018 -A$23.53 Million38.32%
2017 -A$17.01 Million12.51%
2016 -A$15.12 Million25.01%
2015 -A$12.1 Million18.18%
2014 -A$10.24 Million39.72%
2013 -A$7.33 Million46.4%
2012 -A$5.01 Million128.32%
2011 -A$2.2 Million-51.47%
2010 -A$4.52 Million35.21%
2009 -A$3.34 Million
2007 -A$5.25 Million607.04%
2006 -A$0.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.8 Billion-2,157.69%๐Ÿ‡บ๐Ÿ‡ธ USA
A$25.89 B 66,581.97%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
A$11.38 B 29,210.12%๐Ÿ‡ซ๐Ÿ‡ท France
-A$0.79 Million-102.01%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-A$0.32 Billion-899.66%๐Ÿ‡บ๐Ÿ‡ธ USA